Clinical trial
GR Defect in Sputum Cells in COPD
NCT00159276 · Imperial College London, Other · Withdrawn
Key facts
| NCT number | NCT00159276 |
|---|---|
| Title | GR Defect in Sputum Cells in COPD |
| Official title | GR Defect in Sputum Cells in COPD |
| Lead sponsor | Imperial College London, Other |
| Collaborators | AstraZeneca Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Procedure |
| Interventions | Induced Sputum |
| Enrollment | 0 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 4, 2024 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: